Results 1 to 10 of about 47,590 (163)
Antimicrobial Resistance Profiles of Pseudomonas aeruginosa in a Korean Community Hospital: In Vitro Activity of Ceftazidime-Avibactam and Other Agents [PDF]
Polish Journal of MicrobiologyThe novel antibiotic ceftazidime-avibactam was introduced in Korea in 2023. This study evaluated the in vitro susceptibility of Pseudomonas aeruginosa isolates from a community-based hospital to various antibiotics, including ceftazidime-avibactam.
Lee Hyo-Jin +6 more
doaj +2 more sources
Synergistic Activity of Three Iranian Medicinal Plants in Combination with Ceftazidime and Neomycin against Bacterial Strains Causing Nosocomial Infections [PDF]
Research Journal of Pharmacognosy, 2022 Background and objectives: This study aimed to investigate the antimicrobial properties of Salvia limbata, Centella asiatica, and Bacopa Monnieri extracts against Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii and methicillin ...
Fatemeh Tavakoli* +3 more
doaj +1 more source
Antibacterial Susceptibility Pattern of S. maltophilia Isolates at A Tertiary Care Hospital, India
Journal of Pure and Applied Microbiology, 2023 A sudden emergence of Stenotrophomonas maltophilia as a primary pathogen both in immunocompromised and immunocompetent individuals has raised a serious concern, as it is associated with significant case fatality ratio.
Mohammed Ashraf Ali Namaji +4 more
doaj +1 more source
Antibiotics, 2023 Elastomeric infusion pumps (EMPs) have been implemented in many fields, including analgesia, chemotherapy and cardiology. Their application in antimicrobials is mainly limited to the outpatient setting, but with a need to optimise inpatient antimicrobial
Joseph Spencer-Jones +3 more
doaj +1 more source
Antimicrobial Effect of Zinc Oxide Nanoparticles against Multidrug-Resistant Acinetobacter baumannii
Journal of Medical Microbiology and Infectious Diseases, 2023 Introduction: Increased multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) infections pose a significant challenge in hospital settings.
Nader Mashayekh1 +3 more
doaj +1 more source
Virulence, 2020 Patients with Acinetobacter baumannii bacteremia treated with antipseudomonal cephalosporins showed higher 14-day mortality than patients treated with antipseudomonal carbapenems.
Chun-Hsiang Chiu +9 more
doaj +1 more source
Mediterranean Journal of Hematology and Infectious Diseases, 2022 Background: P. aeruginosa sepsis in immunocompromised patients is serious complication of cancer treatment, especially in case of XDR pathogen. The purpose of the study is to evaluate the efficacy of high-dose ceftazidime in treatment of XDR P ...
Alzbeta Zavrelova +5 more
doaj +1 more source
Pharmaceutical Technology in Hospital Pharmacy, 2023 Ceftazidime (CZ) and Vancomycin (VM) are used to treat bacterial keratitis; however, their physicochemical incompatibility does not allow their co-administration.
Plaidy Pauline +4 more
doaj +1 more source
Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis
Indian Journal of Ophthalmology, 2022 Purpose: Real-life comparison of three intravitreal drug regimens used in cases of endophthalmitis at a tertiary care center in India. Methods: In this prospective, comparative study, patients of bacterial endophthalmitis were grouped according to ...
Aafreen Bari +10 more
doaj +1 more source
Hydrolysis of cefazolin by enzymes produced by Pseudomonas aeruginosa after exposure to ceftazidime in vitro [PDF]
Vojnosanitetski Pregled, 2009 Background/Aim. Sometimes resistance of Pseudomonas aeruginosa (Ps. aeruginosa) is developed during antibiotic treatment, in spite of the initial susceptibility in vitro. The aim of this study was to use an in vitro model for the study of the development
Papaioannidou Paraskevi +2 more
doaj +1 more source